Cell Culture World Congress 2016 interview’s Herve Broly, Vice President Biotech Process Development, Merck Serono SA

Ahead of the Cell Culture World Congress 2016, we spoke to Herve Broly, Vice President Biotech Process Development, Merck Serono SA. Herve addresses what he believes to be the biggest achievements within the industry over the past year and lets us know what we can expect from his participation in Munich next February. 1. What do you think have been …

Addressing the key challenges for drug safety professionals

The regulatory environment is fast changing and the drug safety industry is facing significant hurdles in implementing standards globally. It is becoming increasingly challenging to meet all regulatory requirements effectively in the current globalised marketplace.┬áStay on top of pharmacovigilance requirements with updates directly from the regulators, agencies and industry who will show you how to implement regulatory standards globally. Learn …

Spotlight back on Antibiotics Market

Thought to be undervalued and overshadowed by the bigger revenue draw from blockbuster drug manufacturing, Merck’s ($MRK) recent acquisition of Cubist ($CBST) might have placed a spotlight back to the Antibiotics Market. Unlike its compatriots in the biologic therapeutics market, antibiotics target specifically on bacterial infections. More often than not, the efficacy of antibiotics decreases through the misuse of antibiotics. …